期刊文献+

新型冠状病毒感染性肺炎中成药的合理使用 被引量:15

Rational Use of Chinese Patent Medicines for Novel Coronavirus Pneumonia
下载PDF
导出
摘要 新型冠状病毒(SARS-CoV-2)属于β属新型冠状病毒,具有强传染性和传播力,引起国内外的广泛关注和重视。鉴于大多数呼吸科或感染科医生为西医背景,对中药相关知识相对缺乏。该文依据《新型冠状病毒肺炎诊疗方案》第5版的指导意见,制定新型冠状病毒感染性肺炎中成药的合理使用要点,以期为临床医生提供参考。 SARS-CoV-2 belongs to the new type of the genus betacoronavirus,which has strong infectivity and transmission power.The epidemic situation has attracted wide attention in the whole world.Because the academic background of most clinicians of respiratory department or infectious disease department were western medicine,their knowledge of traditional Chinese medicine is relatively lacking.Based on the guidelines of the fifth edition of"pneumonia diagnosis and treatment program for novel coronavirus infection",make a reference to the clinicians about the rational use of the Chinese patert medicine for the novel coronavirus infectious pneumonia.
作者 陈祝君 边原 杨勇 舒永全 童荣生 闫峻峰 何林 龙恩武 陈岷 CHEN Zhujun;BIAN Yuan;YANG Yong;SHU Yongquan;TONG Rongsheng;YAN Junfeng;HE Lin;LONG Enwu;CHEN Min(Personalized Drug Therapy Key Laboratory of Sichuan Province,Department of Pharmacy,Sichuan Academy of Medical Sciences,Sichuan Provincial People’s Hospital,Affiliated Hospital of University of Electronic Science and Technology of China,Chengdu 610072,China;School of Medicine,University of Electronic Science and Technology of China,Chengdu 610054,China)
出处 《医药导报》 CAS 北大核心 2020年第4期489-492,共4页 Herald of Medicine
基金 国家临床重点专科建设资助项目(30305030698) 四川省省级公益性科研院所基本科研业务专项课题资助项目(2018YSKY0017) 四川省人民医院院级科研基金临床研究及转化资助项目(2018LY09)。
关键词 中成药 新型冠状病毒肺炎 合理使用 SARS-CoV-2 Chinese Patent Medicine Novel Coronavirus pneumonia Rational Use SARS-CoV-2
  • 相关文献

参考文献3

二级参考文献63

共引文献229

同被引文献251

引证文献15

二级引证文献220

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部